Skip to main content

Table 6 Multivariate analysis for overall survival including disease stage

From: Serial detection of circulating tumour cells by reverse transcriptase-polymerase chain reaction assays is a marker for poor outcome in patients with malignant melanoma

Marker Hazard Ratio 95% CI P
Sex 1.013 0.46–2.19 0.973
Age 1.011 0.98–1.04 0.480
AJCC Stage (I-III) 2.907 1.24–6.81 0.014
CMC status (0–1 vs ≥2 positive assays) 2.468 1.12–6.23 0.037
  1. CI, confidence interval